People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Biotech / Pharma, Consumer / Retail
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NOLA PharmaHoldings, LLC | — | Biotech / Pharma | Series C | $48.1M | $448.1M | 2024 |
| NE-LA Retail Group LLC | — | Consumer / Retail | Series A | $10.0M | $26.7M | 2025 |
Terry Fitch at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Terry Fitch on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Reid Dove | 1 | 10 |
| Alex Gray | 1 | 9 |
| Peyton Bush | 1 | 5 |
| Stephen LaFrance | 1 | 4 |
| Mitchell Massey | 1 | 3 |
| Todd Denton | 1 | 2 |
| Jason Vedadi | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.